I agree that this site is using cookies. You can find further informations here.
X
Yoo, Suk-Young
16578  results:
Search for persons X
?
1

High response rate with extended dosing of cemiplimab in ad..:

Rischin, Danny ; Hughes, Brett G M ; Basset-Séguin, Nicole...
Journal for ImmunoTherapy of Cancer.  12 (2024)  3 - p. e008325 , 2024
Link: https://doi.org/10.1136/..
 
?
2

Phase 2 open-label, multicenter, single-arm study of cemipl..:

Stratigos, Alexander J. ; Sekulic, Aleksandar ; Peris, Ketty...
Journal of the American Academy of Dermatology.  90 (2024)  2 - p. 414-418 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Neoadjuvant cemiplimab and surgery for stage II–IV cutaneou..:

Gross, Neil D ; Miller, David M ; Khushalani, Nikhil I...
The Lancet Oncology.  24 (2023)  11 - p. 1196-1205 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Primary analysis of Phase 2 results for cemiplimab in patie..:

Lewis, Karl D ; Peris, Ketty ; Sekulic, Aleksandar...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  2 - p. s177 , 2023
Link: https://doi.org/10.25251..
 
?
5

A Phase I/II, multicenter, open-label study of REGN5668 (R5..:

Winer, Ira ; Shields, Anthony ; Yeku, Oladapo...
Gynecologic Oncology.  176 (2023)  - p. S190 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Phase 2 confirmatory study of cemiplimab (350 mg IV Q3W) in..:

Hughes, Brett ; Grob, Jean-Jacques ; Bowyer, Samantha...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  2 - p. s175 , 2023
Link: https://doi.org/10.25251..
 
?
7

Phase 2 study of cemiplimab in patients with advanced cutan..:

Migden, Michael ; Schmults, Chrysalyne ; Khushalani, Nikhil...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  2 - p. s176 , 2023
Link: https://doi.org/10.25251..
 
?
8

Phase 2 study of cemiplimab in patients with locally advanc..:

Stratigos, Alexander J ; Sekulic, Aleksandar ; Peris, Ketty...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  2 - p. s178 , 2023
Link: https://doi.org/10.25251..
 
?
9

Educational intervention for providers addressing the diver..:

Govender, Sarah-Leigh ; Mathias, Melissa ; Fury, Matthew...
Gynecologic Oncology.  166 (2022)  - p. S282 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Tolerability and antitumor activity of cemiplimab, a human ..:

Moreno, Victor ; Garrido, Pilar ; Papadopoulos, Kyriakos P....
Lung Cancer.  155 (2021)  - p. 151-155 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Interim Analysis of Phase 2 Results for Cemiplimab in Patie..:

Lewis, Karl ; Peris, Katty ; Sekulic, Aleksandar...
SKIN The Journal of Cutaneous Medicine.  5 (2021)  1 - p. s3 , 2021
Link: https://doi.org/10.25251..
 
?
12

Integrated analysis of a phase 2 study of cemiplimab in adv..:

Rischin, Danny ; Khushalani, Nikhil I ; Schmults, Chrysalyne D...
Journal for ImmunoTherapy of Cancer.  9 (2021)  8 - p. e002757 , 2021
Link: https://doi.org/10.1136/..
 
?
13

Phase 2 Study of Cemiplimab in Patients with Advanced Cutan..:

Rischin, Danny ; Khushalani, Nikhil ; Schmults, Chryslalyne...
SKIN The Journal of Cutaneous Medicine.  4 (2020)  6 - p. s124 , 2020
Link: https://doi.org/10.25251..
 
?
14

PD-1 blockade in recurrent or metastatic cervical cancer: D..:

Rischin, Danny ; Gil-Martin, Marta ; González-Martin, Antonio...
Gynecologic Oncology.  159 (2020)  2 - p. 322-328 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Exogenous Restoration of TUSC2 Expression Induces Responsiv..:

Dai, Bingbing ; Yan, Shaoyu ; Lara-Guerra, Humberto...
PLOS ONE.  10 (2015)  6 - p. e0123967 , 2015
Link: https://doi.org/10.1371/..
 
1-15